SHORT COMMUNICATION |
|
Year : 2013 | Volume
: 45
| Issue : 6 | Page : 619-621 |
Prevention of injection pain due to propofol by dezocine: A comparison with lidocaine
Yao Lu1, Ye Zhang2, Gordon Tin Chun Wong3, Chunshan Dong4, Junma Yu4
1 Department of Anesthesiology, Second Affiliated Hospital of Anhui Medical University; Third Affiliated Hospital of Anhui Medical University, Hefei 230601, China 2 Department of Anesthesiology, Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China 3 Department of Anesthesiology, University of Hong Kong, Hong Kong SAR, China 4 Third Affiliated Hospital of Anhui Medical University, Hefei 230601, China
Correspondence Address:
Ye Zhang Department of Anesthesiology, Second Affiliated Hospital of Anhui Medical University, Hefei 230601 China
 Source of Support: National Natural Science Foundation of China. (No. 81100105), Conflict of Interest: None  | Check |
DOI: 10.4103/0253-7613.121376
Objectives: The aim of this study was to investigate the efficacy of dezocine (DEZ) versus placebo control (CON) and 2% lidocaine (LID) in prevention of injection pain due to DEZ.
Materials and Methods: A prospective randomized double-blind, placebo-CON study was conducted in 75 adults, American Society of Anesthesiologists physical status I or II, scheduled to undergo an elective surgery. A total of 25 patients were randomly assigned to one of the three groups, thus CON, group LID and group DEZ. The groups received either 2 ml of normal saline or 2 ml 2% LID or 2 mg/2 ml DEZ, respectively, as pre-treatment. Propofol was injected 1 min later. A blinded researcher assessed the patient's pain level using a four point verbal rating scale.
Results: Less patients experienced pain due to propofol injection in the LID (40%) and DEZ (28%) groups compared with the CON (84%) group (P < 0.05). Six patients (24%) in the CON group reported severe pain during propofol injection but none in the other two groups.
Conclusion: Pre-treatment with DEZ decreases propofol injection pain as effectively as LID.
[FULL TEXT] [PDF]*
|